| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.002 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.22 | 0.003 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |